Evidence map›Paper›PMID 22447211›Full record

ArticleJournal of epidemiology2012

Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey.

Yosikazu Nakamura, Mayumi Yashiro, Ritei Uehara, Atsuko Sadakane, Satoshi Tsuboi, Yasuko Aoyama, Kazuhiko Kotani, Enkh-Oyun Tsogzolbaatar, Hiroshi Yanagawa

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of epidemiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 161 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
161citing papers in PubMed, 13 pooled it
39.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

161 citing papers in PubMed, 13 syntheses or guidelines pooled it, 378 citations in OpenAlex.

  1. Pooled it
  2. Corticosteroids for the treatment of Kawasaki disease in children.The Cochrane database of systematic reviews · 2022
    Pooled it
  3. Pooled it
  4. Guideline
  5. [Clinical features of children with recurrent Kawasaki disease: a Meta analysis].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2020
    Pooled it
  6. TNF-α blockers for the treatment of Kawasaki disease in children.The Cochrane database of systematic reviews · 2019
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Corticosteroids for the treatment of Kawasaki disease in children.The Cochrane database of systematic reviews · 2017
    Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Trial
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

101 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yosikazu NakamuraDepartment of Public Health, Jichi Medical University, Shimotsuke, Tochigi, Japan. nakamuyk@jichi.ac.jp
Mayumi Yashiro
Ritei Uehara
Atsuko Sadakane
Satoshi Tsuboi
Yasuko Aoyama
Kazuhiko Kotani
Enkh-Oyun Tsogzolbaatar
Hiroshi Yanagawa
Jichi Medical University Hospital · JPJichi Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough the number of patients and incidence rate of Kawasaki disease (KD) are increasing in Japan, the most recent epidemiologic features of KD are not known.

methodsThe 21st nationwide survey of KD was conducted in 2011 and included patients treated for the disease in 2009 and 2010. Hospitals specializing in pediatrics, and hospitals with a total of 100 or more beds and a pediatric department, were asked to report all patients with KD during the 2 survey years.

resultsA total of 1445 departments and hospitals reported 23,730 KD patients (10,975 in 2009 and 12,755 in 2010): 13,515 boys and 10 215 girls. The annual incidence rates were 206.2 and 239.6 per 100,000 children aged 0 to 4 years in 2009 and 2010, respectively; the 2010 rate was the highest ever reported in Japan. Monthly number of patients peaked during winter to spring months; lower peaks were noted during summer months. However, the seasonal patterns in 2009 and 2010 differed from those of previous years. The age-specific incidence rate had a monomodal distribution, with a peak during the latter half of the year of birth. The prevalences of cardiac lesions during acute KD and cardiac sequelae were higher among infants and older age groups. Despite a decrease in prevalence, the proportion of patients with giant coronary aneurysms-the most severe sequela of KD-did not substantially decrease.

conclusionsThe incidence rate and number of patients with KD continue to increase in Japan.

Indexed as

Age FactorsChildChild, PreschoolData CollectionFemaleHeart DiseasesHospitals, PediatricHumansIncidenceInfantInfant, NewbornJapanMaleMucocutaneous Lymph Node SyndromePrevalenceRetrospective Studies

Identifiers

PMID22447211
PMCPMC3798622
OpenAlexW2050966310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.